Selvita demonstrates dynamic business growth in Q3 2018

Krakow, Poland – 20 November 2018 – Selvita (WSE: SLV), a clinical stage drug discovery and development company engaged in the research and development of novel cancer therapies, has recently published quarterly financial results demonstrating its continued dynamic business growth. In Q3 2018 Selvita Group recognized total commercial revenue (not…

More

Selvita presents at BIO-Europe 2018

Kraków, Poland – 2 November 2018 – Selvita (WSE: SLV), a clinical stage drug discovery and development company focused on innovative medicines for oncology patients and drug discovery services, will participate and present at the BIO-Europe 2018 conference, which is taking place on November 5-7, 2018, in Copenhagen, Denmark. The…

More

Selvita presents at the 18th Annual Biotech in Europe Forum

Krakow, Poland – 02 October – Selvita will participate and present at the upcoming 18th Annual Biotech in Europe Forum, which will take place 4 – 5 October 2018 in Basel, Switzerland. The conference is organized by Sachs Associates. Selvita is scheduled to present a corporate overview at 14:15 on Thursday,…

More

...34567...1020...